drugset

drugset / Trial / NCT04839380

The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis

NCT04839380 ↗

Phase 2 Completed 49 enrolled Incyte Corporation

NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the effect of ruxolitinib cream on itch in participants with Atopic Dermatitis.

Timeline

Start: 2021-10-12
Primary completion: 2022-11-18
Completion: 2022-11-18

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ruxolitinib	Small molecule	1.5 %	Topical

Indications